(KDLY) Kindly MD Common Stock - Ratings and Ratios
Healthcare, Behavioral, Therapy, Data, Services
KDLY EPS (Earnings per Share)
KDLY Revenue
Description: KDLY Kindly MD Common Stock
Kindly MD, Inc. is a pioneering healthcare company that integrates medical treatment with behavioral health services, offering a holistic approach to patient care. By providing specialty outpatient clinical services on a subscription and fee-for-service basis, the company complements traditional healthcare models. Its comprehensive services encompass evaluation and management of chronic pain, functional medicine, cognitive behavioral therapy, and more, addressing a wide range of patient needs. Additionally, Kindly MD engages in data collection and research, as well as online and email marketing campaigns, further solidifying its position in the healthcare and healthcare data sectors.
As a relatively new player in the industry, having been incorporated in 2019 and rebranded in March 2022 from Utah Therapeutic Health Center, LLC, Kindly MD has quickly established itself with a strong online presence, as evident from its website (https://kindlymd.com). The companys innovative approach and expanding service portfolio are likely to attract significant attention from investors and patients alike.
Analyzing the available data, its clear that KDLY has garnered substantial interest, reflected in its current market cap of $137.49M USD. Despite the absence of a P/E ratio, indicative of the companys current non-profitable status, the stock has shown remarkable volatility, with an ATR of 2.60, translating to a 10.42% fluctuation. The stocks price action, having surged from a 52-week low of $0.83 to a high of $24.94, suggests a potential for continued growth, driven by the companys expanding services and increasing market presence.
Given the technical indicators, including SMA20 at $8.17, SMA50 at $4.26, and SMA200 at $2.10, the stock is exhibiting a strong uptrend, with the short-term moving averages significantly above the long-term average. This, coupled with the fundamental data indicating a negative RoE of -146.24, suggests that while the company is currently operating at a loss, investor sentiment is positive, driving the stock price upwards. A forecast based on these indicators suggests potential for KDLY to continue its upward trajectory, albeit with high volatility. Investors should closely monitor the companys future earnings reports and expansion plans, as these will be critical in determining the stocks long-term viability and growth potential.
Additional Sources for KDLY Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
KDLY Stock Overview
Market Cap in USD | 150m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Services |
IPO / Inception | 2024-05-31 |
KDLY Stock Ratings
Growth Rating | 40.1 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 449 |
Analysts | - |
Fair Price Momentum | 10.95 USD |
Fair Price DCF | - |
KDLY Dividends
Currently no dividends paidKDLY Growth Ratios
Growth Correlation 3m | 52% |
Growth Correlation 12m | 58.9% |
Growth Correlation 5y | 34.1% |
CAGR 5y | 238.52% |
CAGR/Max DD 5y | 3.21 |
Sharpe Ratio 12m | -0.44 |
Alpha | 380.21 |
Beta | 2.061 |
Volatility | 161.38% |
Current Volume | 250.8k |
Average Volume 20d | 401.5k |
Stop Loss | 10.9 (-7.4%) |
As of July 16, 2025, the stock is trading at USD 11.77 with a total of 250,809 shares traded.
Over the past week, the price has changed by -8.83%, over one month by -22.00%, over three months by +592.35% and over the past year by +400.85%.
Partly, yes. Based on ValueRay´s Analyses, Kindly MD Common Stock (NASDAQ:KDLY) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 40.13 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of KDLY is around 10.95 USD . This means that KDLY is currently overvalued and has a potential downside of -6.97%.
Kindly MD Common Stock has no consensus analysts rating.
According to our own proprietary Forecast Model, KDLY Kindly MD Common Stock will be worth about 13.1 in July 2026. The stock is currently trading at 11.77. This means that the stock has a potential upside of +11.64%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 13.1 | 11.6% |